BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17180637)

  • 21. The relationship between disease activity and depression and sleep quality in Behçet's disease patients.
    Koca I; Savas E; Ozturk ZA; Tutoglu A; Boyaci A; Alkan S; Kisacik B; Onat AM
    Clin Rheumatol; 2015 Jul; 34(7):1259-63. PubMed ID: 24816545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of association between serum IL-9 levels and Behçet's disease.
    Nouri-Vaskeh M; Malek Mahdavi A; Khabbazi A; Jadideslam G
    Immunol Lett; 2019 Jul; 211():23-27. PubMed ID: 31095970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?
    Hammad M; Shehata OZ; Abdel-Latif SM; El-Din AMM
    Clin Rheumatol; 2018 Oct; 37(10):2811-2817. PubMed ID: 29980877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Behcet's Disease Quality of Life: reliability and validity of the Korean version.
    Yi SW; Kim JH; Lim KY; Bang D; Lee S; Lee ES
    Yonsei Med J; 2008 Oct; 49(5):698-704. PubMed ID: 18972588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of fibromyalgia in patients with Behçet's disease and its relation with disease activity.
    Melikoglu M; Melikoglu MA
    Rheumatol Int; 2013 May; 33(5):1219-22. PubMed ID: 23052486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.
    Vitale A; Emmi G; Lopalco G; Fabiani C; Gentileschi S; Silvestri E; Gerardo DS; Iannone F; Frediani B; Galeazzi M; Lapadula G; Rigante D; Cantarini L
    Clin Rheumatol; 2017 Sep; 36(9):2063-2069. PubMed ID: 28401434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial effects of apremilast on genital ulcers, skin lesions, and arthritis in patients with Behçet's disease: A systematic review and meta-analysis.
    Iizuka Y; Takase-Minegishi K; Hirahara L; Kirino Y; Soejima Y; Namkoong HO; Horita N; Yoshimi R; Takeuchi M; Takeno M; Mizuki N; Nakajima H
    Mod Rheumatol; 2022 Oct; 32(6):1153-1162. PubMed ID: 34752620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life impairment in Behçet's disease and relationship with disease activity: a prospective study.
    Fabiani C; Vitale A; Orlando I; Sota J; Capozzoli M; Franceschini R; Galeazzi M; Tosi GM; Frediani B; Cantarini L
    Intern Emerg Med; 2017 Oct; 12(7):947-955. PubMed ID: 28620840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genital ulcer severity score and genital health quality of life in Behçet's disease.
    Senusi A; Seoudi N; Bergmeier LA; Fortune F
    Orphanet J Rare Dis; 2015 Sep; 10():117. PubMed ID: 26394620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Syndrome in Behçets Disease Patients: Keep an Eye on the Eye.
    ElAdle SS; Latif EA; Abdel-Fattah YH; Shebini EE; El-Gazzar II; El-Saadany HM; Samy N; El-Mallah R; Salem MN; Eesa N; Shereef RE; El Khalifa M; Tharwat S; Nasef SI; Ibrahim ME; Khalil NM; Abdalla AM; Abd Elazeem MI; Noor RA; Sallam R; El-Bahnasawy A; Shanawany AE; Senara S; Fathi HM; Bakry SAE; Elsaman A; Najjar AE; Ragab U; Talaat EA; Hammam N; El-Hindawy AK; Gheita TA; Ismail F
    Curr Rheumatol Rev; 2023; 19(2):180-188. PubMed ID: 35692166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
    Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
    Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
    Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
    Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of apremilast for 3 months in Behçet's disease: A prospective observational study.
    Hirahara L; Kirino Y; Soejima Y; Takeno M; Takase-Minegishi K; Yoshimi R; Takeuchi M; Mizuki N; Nakajima H
    Mod Rheumatol; 2021 Jul; 31(4):856-861. PubMed ID: 32996801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central sensitization and its relationship with health profile in Behçet's disease.
    Ayar K; Ökmen BM; Altan L; Öztürk EK
    Mod Rheumatol; 2021 Mar; 31(2):474-480. PubMed ID: 32515630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The status of serum vitamin D in patients with active Behcet's disease compared with controls.
    Khabbazi A; Rashtchizadeh N; Ghorbanihaghjo A; Hajialiloo M; Ghojazadeh M; Taei R; Kolahi S
    Int J Rheum Dis; 2014 May; 17(4):430-4. PubMed ID: 24118939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of bone scintigraphy for the detection of joint involvement in Behçet's disease: Dermatologists' perspectives.
    Seo J; Lee M; Choi MJ; Zheng Z; Cho A; Bang D; Kim DY
    Eur J Dermatol; 2015; 25(5):477-82. PubMed ID: 26394693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behçet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison.
    Sibley C; Yazici Y; Tascilar K; Khan N; Bata Y; Yazici H; Goldbach-Mansky R; Hatemi G
    J Rheumatol; 2014 Jul; 41(7):1379-84. PubMed ID: 24931953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations.
    Lucherini OM; Vitale A; Orlando I; Sota J; Fabiani C; Franceschini R; Simpatico A; Frediani B; Galeazzi M; Tosi GM; Cantarini L
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):110-115. PubMed ID: 30582507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.